HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Twenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term Disability.

AuthorsBruce C V Campbell, Atte Meretoja, Geoffrey A Donnan, Stephen M Davis
JournalStroke (Stroke) Vol. 46 Issue 8 Pg. 2341-6 (Aug 2015) ISSN: 1524-4628 [Electronic] United States
PMID26152294 (Publication Type: Journal Article, Review)
Chemical References
  • Tissue Plasminogen Activator
Topics
  • Administration, Intravenous
  • Cerebral Hemorrhage (chemically induced, epidemiology)
  • Disabled Persons
  • Humans
  • Randomized Controlled Trials as Topic (trends)
  • Risk Factors
  • Stroke (diagnosis, drug therapy, epidemiology)
  • Thrombolytic Therapy (trends)
  • Time Factors
  • Tissue Plasminogen Activator (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: